Page 5 - Oxford University

India Coronavirus Dispatch: Situation remains grim in national capital

Covid may impact vision of some patients, ethical dilemma of denying vaccine to trial participants, UP artisans start selling online-news relevant to India's fight against the pandemic

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: SII

Serum Institute of India said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly

Thailand to sign Covid-19 vaccine agreement with Oxford-AstraZeneca

The announcement comes as other countries in the region like the Philippines prepare to sign similar deals with AstraZeneca

AstraZeneca faces more Covid-19 vaccine questions after manufacturing error

Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one

How a dosing error turned into lucky punch for AstraZeneca and Oxford

"The reason we had the half-dose is serendipity," Mene Pangalos, the head of AstraZeneca's non-oncology research and development, told Reuters

Oxford-AstraZeneca vaccine shows positive results, up to 90% efficacy

Data from global trials to be submitted to the Indian regulator by the end of December

Serum Institute to focus on supplying Oxford Covid vaccine to India first

Poonawalla said the company will be able to produce 400 million doses of AstraZeneca's vaccine by July 2021 and scale up further from there

Covid-19 crisis: Oxford scientists expect vaccine data by Christmas

Pollard said there is no competition between the various research teams, because several vaccines will be needed to bring the global pandemic under control and allow life to return to normal

Oxford-AstraZeneca Covid-19 vaccine shows immune response in older adults

The vaccine causes few side effects and provokes a response in T-cells that target the virus within 14 days of the first dose and a protective antibody response within 28 days of the booster dose

India Coronavirus Dispatch: Oxford vaccine may be a better fit for India

Delhi cemetary running out of space, 74 per cent Delhiites say they want markets shut, Covid immune response is enduring, may protect for decades-news on how the country is coping with the pandemic

Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul

Limited number of doses would not be enough to meet India's demand, adds Niti Aayog member

Indian economy may be recovering faster than anticipated: Oxford Economics

The Indian economy is seen recovering faster than expected and the Reserve Bank is likely to have come to an end of the rate easing cycle, according to global forecasting firm Oxford Economics

'Great day for humanity': Pfizer says Covid-19 vaccine over 90% effective

President-elect Joe Biden said the news was excellent but did not change the fact that face masks, social distancing would be needed well into next year

Britain prepares for Covid-19 vaccine as Oxford forecasts result this year

There are more than 200 candidates under development and the vaccine being developed by Oxford and licensed to British drugmaker AstraZeneca is seen as a front-runner

Oxford Covid vaccine trial results due this year, chief investigator says

The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to be submitted for regulatory approval, along with Pfizer and BioNTech's candidate

UK starts accelerated review for AstraZeneca's potential Covid-19 vaccine

"We confirm the MHRA's (Medicines and Healthcare Products Regulatory Agency) rolling review of our potential Covid-19 vaccine," an AstraZeneca spokesman said

Oxford Covid-19 vaccine prompts immune response among adults: AstraZeneca

The Financial Times reported that the vaccine, being developed by Oxford and AstraZeneca, triggers protective antibodies and T-cells in older age groups. It cited two people familiar with the finding

AstraZeneca's volunteer who died didn't get Covid-19 vaccine: Report

Brazil's health authority Anvisa said it had been informed on Monday of the study volunteer's death and had received a partial report from an international committee assessing the trial's safety

Oxford Covid-19 vaccine doing everything expected', independent study finds

The experts say that the novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immune response.

Oxford says trial of its Covid vaccine will continue amid death report

The university said it can''t comment on specific incidents but an independent review found no reason to be concerned about the safety of the Brazilian trial